Variant report
Variant | nsv983481 |
---|---|
Chromosome Location | chr12:9423000-9426898 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:72)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:9420935..9423914-chr12:9424246..9425796,2 | MCF-7 | breast: | |
2 | chr12:9423490..9426134-chr12:9432405..9434234,2 | MCF-7 | breast: | |
3 | chr12:9423398..9426359-chr12:9434637..9436174,2 | K562 | blood: | |
4 | chr12:9420935..9423914-chr12:9424246..9425796,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
A2MP1 | TF binding region |
ENSG00000111788 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142341169 | chr12:9423121-9423122 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs150272636 | chr12:9423170-9423171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs546653847 | chr12:9423233-9423234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs34335 | chr12:9423238-9423239 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs191074918 | chr12:9423256-9423257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182920252 | chr12:9423334-9423335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538599809 | chr12:9423355-9423356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs186863339 | chr12:9423356-9423357 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs372082721 | chr12:9423365-9423366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191346911 | chr12:9423447-9423448 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs34336 | chr12:9423590-9423591 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs183149772 | chr12:9423603-9423604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371091812 | chr12:9423665-9423666 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs569518999 | chr12:9423689-9423690 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs138924594 | chr12:9423690-9423691 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs149408688 | chr12:9423745-9423746 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs11049914 | chr12:9423765-9423766 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs144772300 | chr12:9423780-9423781 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs377073150 | chr12:9423818-9423819 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs187819287 | chr12:9423899-9423900 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs79211799 | chr12:9423974-9423975 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs191454635 | chr12:9424015-9424016 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs182208356 | chr12:9424047-9424048 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs187559829 | chr12:9424063-9424064 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs138397205 | chr12:9424077-9424078 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs192560587 | chr12:9424102-9424103 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs57512405 | chr12:9424154-9424155 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs185164788 | chr12:9424256-9424257 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs554207047 | chr12:9424266-9424267 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs75135800 | chr12:9424275-9424276 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs575054580 | chr12:9424283-9424284 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs34337 | chr12:9424308-9424309 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
33 | rs73236992 | chr12:9424355-9424356 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs111615097 | chr12:9424397-9424398 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs190098190 | chr12:9424446-9424447 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs141673093 | chr12:9424532-9424533 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs76397473 | chr12:9424539-9424540 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192881521 | chr12:9424579-9424580 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs12581534 | chr12:9424613-9424614 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs571513356 | chr12:9424638-9424639 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs534227131 | chr12:9424656-9424657 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376074793 | chr12:9424710-9424711 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs570305875 | chr12:9424745-9424746 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs80064432 | chr12:9424749-9424750 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565063993 | chr12:9424754-9424755 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs146209905 | chr12:9424801-9424802 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs139140668 | chr12:9424847-9424848 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544148972 | chr12:9424898-9424899 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184962369 | chr12:9424936-9424937 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs149494436 | chr12:9424987-9424988 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Breast cancer | 22032731 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 21965145 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Prostate cancer | 19156837 | CNVD |
Emphysema | 19352772 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Epilepsy | 21858020 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Malignant peripheral nerve sheath tumor | 19844265 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Alzheimer''s disease | 17160897 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:9418800-9423400 | Weak transcription | Hela-S3 | cervix |
2 | chr12:9421200-9425800 | Weak transcription | NHEK | skin |
3 | chr12:9422400-9425800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr12:9423400-9425600 | Enhancers | Hela-S3 | cervix |
5 | chr12:9425600-9426000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
6 | chr12:9425600-9426000 | Flanking Active TSS | Hela-S3 | cervix |
7 | chr12:9425600-9426400 | Enhancers | Muscle Satellite Cultured Cells | -- |
8 | chr12:9425600-9427000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr12:9425600-9427000 | Enhancers | HMEC | breast |
10 | chr12:9425800-9426000 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
11 | chr12:9425800-9426200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr12:9425800-9426400 | Enhancers | NHEK | skin |
13 | chr12:9425800-9426400 | Enhancers | Osteobl | bone |
14 | chr12:9425800-9426800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
15 | chr12:9426000-9426400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
16 | chr12:9426000-9427400 | Enhancers | Hela-S3 | cervix |
17 | chr12:9426400-9429400 | Weak transcription | NHEK | skin |
18 | chr12:9426800-9427000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |